Adams Kendra bought CCCC
February 14, 2024 · Form 4 insider transaction
Adams Kendra bought 36,700 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
36,700
Price
$0.00
Total value
N/A
InsiderAdams Kendra
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2024
Filing dateFebruary 15, 2024
Shares owned after82,039
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025.